Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study
2009

Vardenafil for Treating Tinnitus: A Pilot Study

Sample size: 42 publication 10 minutes Evidence: low

Author Information

Author(s): Mazurek Birgit, Haupt Heidemarie, Szczepek Agnieszka J, Sandmann Jörg, Gross Johann, Klapp Burghard F, Kiesewetter Holger, Kalus Ulrich, Stöver Timo, Caffier Philipp P

Primary Institution: Charité – Universitätsmedizin Berlin

Hypothesis

Does vardenafil have a therapeutic effect on chronic tinnitus?

Conclusion

Vardenafil did not show superior efficacy over placebo in treating chronic tinnitus.

Supporting Evidence

  • Vardenafil did not improve tinnitus scores compared to placebo.
  • Safety profile of vardenafil was consistent with previous studies.
  • Participants reported no significant changes in quality of life measures.

Takeaway

The study tested a medicine called vardenafil to see if it could help people with ringing in their ears, but it didn't work better than a sugar pill.

Methodology

A randomized, double-blind, placebo-controlled trial with 42 subjects receiving either vardenafil or placebo for 12 weeks.

Potential Biases

Potential biases in self-reported outcomes and the small sample size.

Limitations

The study was small and only lasted 12 weeks, which may not be sufficient to observe long-term effects.

Participant Demographics

Participants were adults aged 18 to 65 with chronic tinnitus, predominantly Caucasian.

Digital Object Identifier (DOI)

10.1186/1477-5751-8-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication